Background and purpose: To support clinical decision-making in central neurological disorders, a physical examination is used to assess responses to passive muscle stretch. However, what exactly is being assessed is expressed and interpreted in different ways. A clear diagnostic framework is lacking. Therefore, the aim was to arrive at unambiguous terminology about the concepts and measurement around pathophysiological neuromuscular response to passive muscle stretch.
Introduction
Impaired motor control is a consequence of most central nervous system (CNS) movement disorders such as cerebral palsy, stroke, spinal cord injury or multiple sclerosis (MS). A common physical examination includes assessment of the resistance to passive muscle elongation. This examination is used to make judgements on the degree and nature of muscle hyper-resistance, to determine aetiology at the level of the muscular tissue and/or motor control, and to infer consequences for overall motor performance in functional tasks. It is considered important to a meaningful description of the clinical status of the patient and essential to inform decisions on the treatment options [1] .
Although such physical examination is in widespread clinical use and yields clinically essential information, the concept of what is being assessed cannot be unambiguously phrased. This is expressed in the variety of typically used nomenclature for what is being assessed, e.g. hyper-resistance, spasticity, hypertonia, stiffness, (dynamic) contracture or hypo-extensibility [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . This is accompanied by a variety of interpretations, i.e. how these findings relate to presumed underlying pathophysiology. Therefore, in clinical practice, the concepts of pathophysiological neuromuscular response to passive muscle stretch must be considered implicit rather than explicit. The lack of a clear diagnostic conceptual framework obstructs effective communication between clinicians, and impedes the construction of reliable treatment algorithms. Moreover, quantifying results of an assessment requires grading based on measurement instruments that, by definition, must rely on unambiguous conceptualization.
All in all, this diversity in clinical practices calls for a consensus on the conceptualization, interpretation and measurement of the pathophysiological neuromuscular responses to imposed passive elongation, to fully exploit the potential of this diagnostic test in the context of treating patients with neurological diseases.
General physiological concepts
The aetiology of increased resistance to passive muscle stretch has both neurological and non-neurological components. The primary neurological component is generally accepted as being caused by supraspinal disregulation (disinhibition) of the spinal reflex loop, as a direct result of the neurological insult [12, 13] . This reflex loop evokes a stretch reflex, an essential mechanism of motor control that occurs when a muscle is lengthened rapidly and/or forcefully. Normally, stretch reflex activity is low when a muscle is passively lengthened. In the case of disinhibition due to a neurological insult, the stretch reflex is more readily elicited. This hyperactive reflex causes muscle contraction and therefore an opposing force to passive elongation. In fact, the complete pathophysiology of neural contributors is much more complex than this simplified description, as several mechanisms can be identified that give rise to involuntary muscle contractions resulting in increased resistance of muscles to their elongation. These mechanisms are referred to as excess, or positive motor symptoms, of the neurological disorder, as opposed to the deficit, or negative symptoms, that reflect the impairment to activate a muscle purposefully.
The non-neurological component of muscle hyperresistance consists of secondary impairments that are thought to occur as a result of muscular adaptations to the neural dysregulation. For instance, muscles might shorten (muscle contractures) or stiffen due to intrinsic changes in the muscle tissue. In children these effects might be amplified as result of maladaptation to growth.
Definitions
Pathophysiological responses to passive muscle elongation have been defined and named. The use of the term 'spasticity' has been used to refer to either an aetiology at spinal level or to a clinical expression at a joint level. Such wide usage of the term has led to its definition being subject to debate for a long time [6, 7] . One of the commonly used definitions of spasticity was provided by Lance in 1980: 'a motor disorder characterized by a velocity dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from hyper excitability of the stretch reflex, as one component of the upper motor neurone syndrome' [3] . Clearly, Lance refers to the pathophysiological mechanisms. Sanger et al. (NIH task force, 2003) stayed closer to the clinical phenomena and defined spasticity as 'hypertonia in which one or both of the following signs are present: (i) resistance to externally imposed movement that increases with increasing speed of stretch and varies with the direction of joint movement, and/ or (ii) resistance to externally imposed movement rises rapidly above a threshold speed or joint angle' [4] . Other features of neuromuscular impairments were defined by them as well, all under the umbrella term 'hypertonia'. The definitions by Lance and by Sanger et al. are mutually compatible.
In 2005, the SPASM consortium introduced a new definition of spasticity using a motor control approach: 'disordered sensori-motor control, resulting from an upper motor neurone lesion, presenting as intermittent or sustained involuntary activation of muscles' [8, 9] . This definition includes the entire range of signs and symptoms that are collectively described as excess features and not exclusively the hyperactive stretch reflex.
Common clinical tests
Several physical examination tests have been constructed to assess spasticity or resistance in clinical practice, such as the (modified) Ashworth Scale (MAS), the Tardieu Scale and the Spasticity Test (SPAT, a simplification of the Tardieu Scale) [1, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . In these tests, passive muscle elongations are imposed at one or more velocities by the examiner. Perceived resistance during slow passive elongation is assumed to be related only to non-neural [changed mechanical response of the neuromuscular complex, i.e. stiffness (elasticity) and viscosity] components. In muscles with spasticity, high stretch velocities may additionally cause increased resistance and/or a catch, i.e. a stop in the movement due to the hyperactive stretch reflex [15, 26] . In contrast to the Tardieu Scale and the SPAT, the MAS does not use multiple velocities and scores a single value, thereby not discriminating between neural and non-neural contributions [21] .
Although such physical examinations are commonly used in clinical practice, the resistance perceived by the examiner is difficult to relate to either a neural or a non-neural origin [7, 27] . Moreover, the velocity of stretch as well as the level of activity of the muscle are uncontrolled [7, 16, 19, 23, 28] . Finally, the outcome of these tests is a numeric value scored by the examiner and based on subjective feelings and joint angle measurement with goniometry. Standardization, reliability, sensitivity, quantification and objectivity are lacking in these tests.
Instrumented tests
To unravel the neural and non-neural contributions to hyper-resistance during passive muscle elongation, instrumented assessments have been developed in several research settings [7, 16, 22, 24, [26] [27] [28] [29] [30] . These measurements employ electrophysiological signals [electromyography (EMG)] to assess the stretch reflex, in combination with joint movement (kinematics) and applied torques (net joint moment). In this way the resistance to muscle elongation can be objectified and the neural and non-neural aspects specifically discriminated, in order to arrive at the correct treatment option based on aetiology [28, 29] . Next to assessment of the stretch reflex, the measurement of the Hoffman reflex, using submaximal electric stimulation of the nerve, is used to study the excitability of the Ia afferents [25, 31, 32] .
Although there have been multiple efforts to arrive at clear concepts, and instruments are developed to express objectivity, there is yet no unambiguous and generally accepted conceptual framework that incorporates a meaningful decomposition of perceived phenomena with associated operationalization. Therefore, two consensus meetings were organized with the aim (i) to arrive at unambiguous terminology about the concepts of, and phenomena around, pathophysiological neuromuscular response to passive muscle stretch and (ii) to define requirements from a clinical perspective that enable the development of instruments to quantitatively measure the defined concepts in clinical practice.
Methods
Thirty-seven participants from 12 European countries joined two consensus meetings, on 22-23 May 2014 in Amsterdam, the Netherlands, and a follow-up meeting on 8 September 2015 in Heidelberg, Germany. Participants from, but not restricted to, the network of the organizers (JN, JH, JB, LB, KD) were invited for the meetings based on their publications related to this field and their experience in either treating or assessing spasticity in a clinical or research setting. Prior to the first meeting, participants were asked to fill in an online questionnaire (NETQ Internet Surveys, NetQuestionnaires Nederland BV, Utrecht, The Netherlands) about their background and experience with clinical spasticity assessment. The characteristics of the participants are presented in Table S1 . During the meetings, a modified Delphi approach [33] was used to arrive at a consensus about (i) terminology about the concepts of, and phenomena around, response to passive muscle stretch and (ii) boundary conditions from a clinical perspective to enable the development of instruments to quantitatively measure the defined concepts in clinical practice.
Part 1
At the first meeting (31 participants), a schematic overview (Fig. 1a) was presented to the participants. This overview was developed by the organizers of the consensus meetings (JH, JB, KD, LB, JN) based on a careful review of the literature (as described in the Introduction) and their own experience in the field, with the aim of initiating a discussion on concepts and (new) terminology. Using this overview, a discussion was initiated on the terminology, concepts and phenomena around pathophysiological neuromuscular responses to passive muscle stretch. Thereafter, a Delphi questionnaire, consisting of 12 statements using a Likert scale (i.e. strongly disagree, disagree, neutral, agree, strongly agree) (Table S2 ) was anonymously filled in by the participants (NETQ Internet Surveys). The included domains were: terminology on the concepts, non-neural and neural contributions, and passive versus active impairment.
Subsequently, the results of this first round were collated, presented to participants and discussed plenary. Consensus was reached when agreement was 75% or higher. Unclear questions from round 1 were rephrased and a second Delphi round of eight statements was conducted (Table S3 ) on the same domains. Next, the results of the second round were presented to the participants and discussed plenary to further reach consensus on those statements that were unclear or had limited agreement.
During the second meeting (26 participants), a summary of the results of the two Delphi rounds and the discussions of the first meeting were presented, followed by a plenary discussion for final agreement on conceptualization and terminology.
Part 2
To determine the requirements for instrumented measurement of the defined concepts in clinical and research practice, designs and data from previous instrumented setups developed in research settings were presented to the participants at the first meeting (as described in the Introduction). Subsequently, a Delphi round on concepts of measurement was carried out which included 75 questions or statements (Table S4 ) related to the following domains: pathology, muscles, inclusion and exclusion criteria, test time allowance, patient position, movement profile, theoretical importance of signals and sensors, practical feasibility of signals and sensors, feedback, outcome parameters, report and training. Questions were multiple choice or used the Likert scale. Results of the questionnaire were discussed plenary.
During the second meeting, a second Delphi round about concepts of measurements was conducted which included 18 rephrased statements that were unclear to the participants or had not reached consensus in round 1. The included domains were: protocol, feedback and report.
As instrumented measurement of spasticity in clinical settings is still fairly innovative, the aim of part 2 was not to reach full consensus on all questions but to get insight into important aspects for future development of a clinically applicable instrumented spasticity assessment.
Results

Participant characteristics
Twenty-seven participants completed the online questionnaire about background, profession and experience with clinical spasticity assessment. Most responders were clinicians (86%) as well as researchers (86%), 71% of the responders clinically assessed patients with spasticity and 48% carried out clinical treatment of spasticity. Years of experience in assessing or treating spasticity ranged between 1 and 30 years, with a mean of 13 years and median of 15 years. The (modified) Tardieu Scale was the most commonly used clinical test (57%) followed by the MAS (53%). Tests were mostly performed by physiotherapists (76%) or medical doctors (71%), most of the time before and after treatment (67% always before and after) and sometimes during consultations (62%). Most responders were unsatisfied with the current clinical tests (47%) or were neutral (33%). Of the participants using a form of instrumented assessment (81%), 24% were unsatisfied and 38% neutral.
Part 1: Conceptualization and terminology
Twenty-eight participants completed the first and 30 participants completed the second Delphi round on the conceptualization of the pathophysiological neuromuscular responses to passive muscle stretch (Tables S2 and S3 and Appendix S1).
In the initial plenary discussion following the presentation of the schematic overview (Fig. 1a) , the following were discussed. (i) Increased resistance perceived by an examiner during physical examination, i.e. passive muscle stretch, apart from the term spasticity is often termed hypertonia, which implies that the resistance results from involuntary muscle activation. (ii) However, since hypertonia may also exist at rest (without muscle stretch), it may not be equated to the resistance perceived during stretch. Therefore, the term hyper-resistance was suggested. (iii) Although still the most commonly used term in clinical practice, it was also suggested to be careful with the term spasticity, since it may not cover all aspects of the perceived resistance.
During the first Delphi round (Table S2) , it was concluded that the term 'hyper-resistance' is preferred over the terms 'hypertonia' and 'spasticity' to describe the phenomenon of impaired neuromuscular response during passive stretch. Hyper-resistance is therefore defined as increased resistance perceived during passive muscle stretch.
It was agreed that it is essential to distinguish nonneural (tissue-related) from neural (CNS-related) contributions to hyper-resistance. It was proposed that the different contributions could be described by three subgroups: muscle tissue properties (non-neural), hyperstretch reflex (neural and induced by motion) and involuntary activation (neural) (Fig. 1b) . Muscle tissue properties consist of muscle stiffness (elasticity) and viscosity. Participants remarked that joint stiffness and viscosity are not only the result of muscle tissue properties but are also influenced by the ligaments and surrounding tissue. However, hyper-resistance reflects neuromuscular unit function only when no bony and ligament response is assumed (second Delphi round, Table S3 ).
During the first Delphi round (Table S2 ) consensus was reached that it is essential to distinguish hyperstretch reflex and other muscle activity within the neural (CNS-related) contributions to hyper-resistance. Clonus and clasp-knife are specific manifestations of the exaggerated stretch reflex. In the discussion prior to the first Delphi round it was suggested that hyperresistance is the net effect of the agonist and 
Requirements
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Hyper-resistance antagonist muscles, and co-contraction might be present during examination. Therefore, co-contraction should be considered as part of the involuntary activation subgroup. In the second Delphi round (Table S3) , the majority of the participants agreed that hyper-resistance reflects the neuromuscular unit function of an agonist muscle group only when no effects of antagonistic muscle(s) (shortening) is assumed.
In the discussion prior to the second Delphi round, three alternatives were proposed for terminology of the two neural contribution subgroups to hyper-resistance, i.e. 'hyperstretch reflex' and 'involuntary activation' (Fig. 1b) . In the second Delphi round (Table S3) , consensus was reached that the neural contributions to hyper-resistance must be distinguished in 'velocity dependent involuntary activation' and 'non-velocity dependent involuntary activation'. Also the terms 'stretch hyperreflexia' and 'involuntary background activation' were considered to be appropriate as alternative terms to distinguish different neural contributions (Fig. 1b) and were further used in the final discussions in combination with the term '(non-)velocity dependent' (Fig. 1c) . Participants showed less preference for the terms 'stretch reflex involuntary activation' and 'nonstretch reflex involuntary activation'.
In the final discussions of the conceptualization phase (following the two Delphi rounds), the characteristics of subgroups of hyper-resistance were further specified (Fig. 1c) .
(Muscle) tissue properties (non-neural) involve elasticity, viscosity and shortening. The neural contributions are subdivided into stretch hyperreflexia (velocity dependent) and involuntary background activation (non-velocity dependent). Postural reflexes, non-selective activation, tonic reflexes and fixed background tone are all part of the involuntary background activation.
The word 'spasticity' is not part of the conceptual framework, since almost all participants (strongly) agreed that the term spasticity should be used with care and only when clearly defined (Table S3) . Also, participants agreed that the term refers to involuntary, stretch velocity induced muscle activity as part of the neural contributions to hyper-resistance (definition according to Lance and Sanger et al. [3, 4] ) (Tables S2  and S3 ). Therefore, within the framework, spasticity refers to velocity dependent stretch hyperreflexia as part of hyper-resistance and should only be used next to the term 'stretch hyperreflexia'. Also, the term 'stiffness' is not part of the conceptual framework. It is mechanically defined as the linear relation between joint angle and joint moment (i.e. elasticity); however, in practice the term 'stiffness' is often used in a broader perspective to refer to various (muscle) tissue properties. In this case, it should only be used next to the term (muscle) tissue-related contributions to hyper-resistance.
Finally, it was discussed whether passive measurement is representative of the problems occurring during active, functional tasks. Hyper-resistance [International Classification of Functioning, Disability and Health (ICF) body functions and structures level, WHO 2001 [34] ) only partly determines any impaired muscle function during performance of activities (ICF activity level) (Table S2 ). Further research should compare the hyper-resistance measured during passive and active movements.
Part 2: Requirements for instrumented measurement of hyper-resistance
Twenty-eight participants completed the first questionnaire, and 19 participants completed the second questionnaire about concepts of measurement. Outcomes (Tables S4 and S5 and Appendix S1) showed that an instrumented assessment of hyper-resistance must be applicable to children (>3 years) and adults with cerebral palsy, stroke, spinal cord injury and MS. The main muscle groups that need to be assessed are (lower limb) medial and lateral gastrocnemius, soleus, rectus femoris, hamstrings (semimembranosus and semitendinosus) and to a lesser extent hip adductors, as well as (upper limb) elbow and wrist flexors. It is required that patients must be in a comfortable position that promotes muscle relaxation during the test.
The test procedure must start from the minimum end of the range of motion (corresponding to the shortest muscle length) to the maximum end of the range of motion (corresponding to the longest muscle length). The assessment is not applicable to joints with fixed deformities or muscle contractures that limit the range of motion in the direction of movement to less than 10°. At least two different stretch velocities are required (slow and fast), the number of stretches must be kept to a minimum and a rest period is necessary between repetitions. It is important to hold the end of the stretch for a minimum amount of time in order to capture differences in type of catch (e.g. 2-5 s). Feedback on the achieved stretch velocity, muscle activity (agonist and antagonist), range of motion in direction of movement and force applied in main direction of movement are essential.
From the first Delphi round (Table S4) , requirements for outcome parameters of instrumented assessment concerning neural contributions (either available in a report or in raw data that can be processed post hoc) are the amount of reflex activity measured by EMG (i.e. mean amplitude over a certain period), the timing of EMG activation, duration of EMG activity and increase in EMG amplitude due to velocity and due to position separately. Essential non-neural-based parameters are start and end joint angle, joint range of motion (ROM) and angle of catch (AOC) [28] , as well as maximal angular velocity. A clinical report of instrumented assessment should contain at least discrete values of the recommended outcome parameters and comparisons of the data with typically developing/healthy subjects, as well as pre-or post-treatment comparisons.
Following this, in the second Delphi round (Table S5 ) it was agreed that for a slow stretch the following five outcome parameters would be sufficient in a report: ROM, maximal angular velocity, average root mean square EMG, stretch reflex threshold (i.e. joint angle at which EMG onset is first detected) and average work. Eighteen per cent of the participants also indicated that stiffness (i.e. elasticity: the linear relation between joint angle and joint moment) might be a valuable outcome parameter for a slow stretch. For a fast stretch, six outcome parameters should be included: maximal angular velocity, average root mean square EMG, stretch reflex threshold, average work, AOC and intensity of catch. As a difference between slow and fast stretch three outcome parameters should be included: difference between ROM and AOC, difference in average root mean square EMG, and difference in work.
By these requirements, the three components in the conceptual framework of the pathophysiological neuromuscular responses to passive muscle stretch (muscle tissue properties, stretch hyperreflexia and involuntary background activation) could be linked to instrumented measurement of the joint angle, net joint moment and EMG to quantify the components of hyper-resistance (Fig. 1c) .
Discussion
A conceptual framework of the pathophysiological neuromuscular responses to passive muscle stretch was defined. This framework enables unambiguous terminology and a clear definition of the contributions to the clinical phenomenon of hyper-resistance that can be used in clinical practice and instrumented assessment. This will optimize communication between clinicians, improve diagnostics and objectify treatment outcomes.
In summary, the participants concluded that the term 'hyper-resistance' should be used to describe the phenomenon of the pathophysiological neuromuscular responses to passive muscle stretch, instead of spasticity or hypertonia. Furthermore, it was considered essential to distinguish non-neural (tissue-related) from neural (CNS-related) contributions to hyperresistance. Tissue properties consist of elasticity, viscosity and muscle shortening. The neural contributions are two-fold: velocity dependent stretch hyperreflexia and non-velocity dependent involuntary background activation. The term 'spasticity' should be used with care, only when clearly defined, next to the term 'stretch hyperreflexia'. The same holds for the term 'stiffness', which should only be used next to tissue-related contributions to hyper-resistance.
The components of hyper-resistance in the framework can be quantitatively assessed using instrumented measurement of the joint angle, net joint moment and EMG during slow and fast passive muscle stretch. Instruments such as gyroscopes, accelerometers, force sensors and EMG sensors can be used to obtain these signals [16, [26] [27] [28] 30] . A list of outcome parameters to be derived from the signals was determined.
Clinical implications
The framework and the related requirements for instrumented assessment as defined by the consensus describe and measure the pathophysiological neuromuscular responses to passive muscle stretch. Some aspects of the defined parameters have already been validated in various patient groups, compared to clinical scores and assessed pre-post treatment [22] . Further experimental validation of the proposed parameters to measure hyper-resistance could be used to advance treatment algorithms that are based on aetiology of the clinical phenomena. In clinical practice, however, physical examination is only one part of the clinical routine, reflecting only some aspects of the 'body functions and structures' level of the ICF, upon which clinicians base their diagnoses and prognoses of treatment plans [34] . As such, clinical decision-making in relevant patient groups is not solely based on passive tests but also involves clinical gait analyses [35] and assessment of the 'activity' and 'participation' domains of the ICF.
In the online questionnaire filled in prior to the first consensus meeting, 47% of the participants indicated that they were unsatisfied with the current clinical tests (Table S1 ). Furthermore, 24% of the responders were unsatisfied with the currently available instrumented assessments. These findings might be related to experience with the commonly used Ashworth scale which is not standardized, not reliable, not discriminative and poorly related to reflex muscle activity [21] . Dissatisfaction with instrumented assessment might be related to too complex instruments that are not suitable for clinical use (like robotic systems), or too simple measures that are not precise or do not measure multiple parameters (like goniometry) [16] . Also, instrumented measurements can be time consuming which may limit their use in clinical practice. These factors stress the fact that clear terminology on the concepts of the pathophysiological responses is needed, as well as development of instrumented measurement that is meaningful towards these concepts and easily applicable in clinical practice. To further assess clinical and research applicability, it is essential to formally investigate the clinical feasibility, patient and assessor usability and friendliness of any developed instruments.
Low correlations between clinical scales like the Ashworth and instrumented assessments have been reported [18, 21, 23] . The new framework helps explain these findings, and may lead to recommendations for use of existing clinical scales or development of new scales. Assessment of the sensitivity of parameters, measured with an instrument, to different treatments might lead to classification of treatments based on the three components of the framework, e.g. botulinum toxin type A, baclofen and selective dorsal rhizotomy (related to neural contributions) or orthopaedic surgery, casts or splints (related to non-neural contributions) [36] .
The defined requirements on instrumented measurement also provide some guidelines for the assessment of patients such as patient position, ROM, muscle stretch velocities and use of outcome parameters needed for clinical decision-making (related to the framework). The posture of the patient influences the muscle length [10, 37] and should therefore be standardized. Some studies have already described standardized postures and movements for some clinical hyper-resistance tests [15, 16, 38, 39] . With regard to stretch velocity and interpretation of outcome parameters, it needs to be realized that in some cases it might be difficult to differentiate the neural and non-neural components of hyper-resistance, e.g. if a fast velocity cannot be obtained due to altered muscle properties (shortening, elasticity) or high background activation.
It was not the aim of the consensus meetings to develop a new definition of spasticity to be used in clinical and research practice. However, agreement was reached that the term 'spasticity' should refer to stretch reflex activity, in accordance with Lance's and Sanger's definitions (Tables S2 and S3 ). More importantly, the consensus stated that the term 'spasticity' should be used with care. Avoiding the word 'spasticity' may not be easy in clinical practice as it is still widely used. Therefore, it is advised to only use the term when clearly defined and next to the term 'stretch hyperreflexia' (Fig. 1c) .
Further directions
Some components in the proposed framework need further clarification. The non-velocity dependent, involuntary background activation that can sometimes be observed during slow passive muscle stretch might also be influenced by other phenomena [10] . Also, if patients are not able to completely relax during the testing, assist or oppose an imposed movement, or experience pain during the movement, it might be difficult to discriminate this muscular activation from pathological involuntary background activation. Therefore, it should be a future aim to develop methods that can distinguish underlying factors in background muscle activation. Different requirements for detecting the different non-neural and neural contributions to hyper-resistance were proposed. Two stretch velocities were advised (slow and fast). However, it is yet not defined what velocity and movement profile should be applied. In physical examination the movement profile is determined by constraints of human performance of the examiner, as opposed to motorized tests in which a particular movement profile can be imposed [40] [41] [42] [43] . However, a motorized test is less feasible in clinical practice and constant velocities do not represent natural movement profiles [44] . To standardize the movement profile in manual testing feedback on achieved stretch velocity, range and direction of movement can be provided. This might be different for each muscle, per age range and patient population, as a consequence of muscle length, initial position, muscle volume and weight of the body segment. For future research it is advised to establish further guidelines on movement velocity, either in ranges or thresholds.
Previous research suggested that reflex activity is both length and velocity dependent [10, 37, 38] . The effect of muscle length might possibly be established using the slow passive movement, taking into account the delay between the trigger and the electrical response and the delay between the electrical and mechanical response of specific muscles [26, 45] . For example, the delay between maximal joint angular velocity and stretch reflex threshold might be an additional valuable outcome parameter in instrumented assessment. Furthermore, as mentioned before, the posture of the patient influences the muscle length [10, 37] and should therefore be standardized.
Clinical research will most certainly benefit from the recommended framework and instrumented assessment. It ensures the use of similar terminology and standardization in measurement, leading to data comparison and data pooling and, with that, a framework to investigate many clinically relevant research questions. This in turn will support clinicians by providing detailed information on the underlying pathology and effectiveness of treatment.
Further, instrumentation and standardization of performance of passive muscle stretch in clinical practice will enable pre-post intervention comparisons and may optimize precision diagnostics and patient-specific treatment. This requires experimental validation of the proposed outcome parameters obtained from instrumented measured joint angles, joint moments and EMG, which is the subject of further study.
Limitations of the study
Since, next to clinicians, both researchers and non-physicians were also invited to participate in the consensus, not all participants personally treat spasticity in daily clinical practice (48% do, Table S1 ). However, all participants are experienced in either assessing or measuring hyper-resistance in a clinical (71%) or research setting (81%). Furthermore, 86% of the participants were clinicians responsible for clinical decision-making, executing the physical examinations or working as part of a multi-disciplinary team that treats spasticity. Since the consensus was focused on concepts of assessment and measurement, the participants very well represent the professionals in the field related to this topic. As it is believed that close collaboration between clinicians and (applied) researchers is key to a better understanding of the complex phenomena, and hence to better treatment in the future, the heterogenetic composition is considered an asset of the study.
The first schematic overview presented was developed by the organizers of the consensus meetings, as was the first round of Delphi questionnaires. This might have introduced bias. However, the aim of the first overview and the first generation of statements (based on careful review of the literature and own experience) was to discuss, to rephrase the statements and to reach consensus. The Delphi method [33] is specifically designed to work in this way.
Conclusion
A conceptual framework of the pathophysiological neuromuscular responses to passive muscle stretch was defined, based on European consensus meetings with experts in the field. The neutral term hyper-resistance should be used to describe the phenomenon of impaired neuromuscular responses during passive stretch. It is essential to distinguish non-neural from neural contributions to hyper-resistance. This framework can be used to standardize and objectify the clinical assessment of hyper-resistance and will improve communication between clinicians and researchers. Components within the framework are defined by objective parameters that can be derived from instrumented assessment. These parameters need experimental validation after which they can be used as part of the development of treatment algorithms that are based on the aetiology of the clinical phenomena. nization of the first consensus meeting in Amsterdam was partly supported by Allergan and by Medtronic. A location for the second consensus meeting was kindly provided by Dr Sebastian I. Wolf and Dr Thomas Dreher of Heidelberg University.
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